IGF-1 DES 1,3Check methods and identity
What a cultured ovarian-cell experiment measured about progesterone
1 numbered sourceSource years 1992
Short chains of amino acids joined by peptide bonds can serve as signals between neighboring cells. IGF-1 DES 1,3 refers here to des(1–3)IGF-1, a 67-amino-acid form missing the first three residues of full-length IGF-1. Researchers used the shortened molecule to ask how locally produced binding proteins influence a hormone response in cultured ovarian cells. [1]
No recent primary study addressing this exact laboratory question was identified. In an older experiment, investigators grew granulosa cells from rats. These are ovarian cells that surround and support a developing egg. The researchers measured progesterone that accumulated in the medium when the cells were stimulated with follicle-stimulating hormone and compared the effects of adding either full-length IGF-1 or the shortened version. When the cells' binding proteins were present, the shortened form had a stronger effect at lower concentrations in that assay. [1]
The comparison was a way to probe the role of the binding proteins the cells released. The shortened form was relatively weak at binding those proteins while retaining activity through the IGF receptor. If more of the shortened molecule remained available to reach the receptor in the experiment, that could account for the difference between the two forms. The authors used the pattern to investigate how cells may regulate access to locally produced growth factors. [1]
The measured outcome was progesterone accumulating in a dish. That does not establish the same response in an intact ovary, or effects on ovulation, pregnancy or fertility in humans. The experiment used the truncated molecule as a tool for separating parts of a signaling pathway. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
- 1.Adashi EY et al. Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action. Evidence derived from the use of a truncated IGF-I analogue. Journal of Clinical Investigation (publication 1992-10). (opens in a new tab)
pubmed.ncbi.nlm.nih.gov↩ Back to text
